Compositions and methods for treating pancreatic tumors

Details for Australian Patent Application No. 2008258503 (hide)

Owner INSERM (Institut National de la Sante et de la Recherche Medicale) Universite de la Mediterranee Innate Pharma S.A.

Inventors Lombardo, Dominique; Crescence, Lydie; Mas, Eric; Gauthier, Laurent; Rossi, Benjamin

Agent Davies Collison Cave

Pub. Number AU-A-2008258503

PCT Pub. Number WO2008/148884

Priority 60/942,777 08.06.07 US

Filing date 6 June 2008

Wipo publication date 11 December 2008

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

17 December 2009 PCT application entered the National Phase

  PCT publication WO2008/148884 Priority application(s): WO2008/148884

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008258505-Multiple analysis of blood samples

2008258500-The puro-DHFR quadrifunctional marker and its use in protein production